Precision Medicine and Pharmacometabolomics Task Group

The Precision Medicine and Pharmacometabolomics Task Group seeks to catalyze the engagement of our metabolomics community in global initiatives in precision medicine. We will create communication channels to facilitate the incorporation of metabolomics data as a compliment to genomics data in informing about disease heterogeneity and treatment outcomes. We seek to facilitate advancements in the field of Pharmacometabolomics and as enabling tool for Precision Medicine.

Rima Kaddurah-Daouk Duke (USA)
Warwick Dunn University of Birmingham (UK)
Michael A Schmidt Sovaris Aerospace, LLC (USA)
Steven S. Gross Weill Cornell Medical College (USA)
Jennifer A. Kirwan Max Delbrück Center/Berlin Institute of Health (Germany)
Marta Cascante University of Barcelona (Spain)
Lorraine Brennan University College Dublin (Ireland)
David S. Wishart University of Alberta (Canada)
Matej Oresic University of Turku (Finland)
Thomas Hankemeier Leiden University (Netherlands)
Andrew Lane University of Kentucky (USA)
Karsten Suhre Weill Cornell Medical College (Qatar)
Gabi Kastenmüller Helmholtz Center Munich (Germany)
Krista Zanetti National Cancer Institute (USA)
Richard D. Beger US Food & Drug Administration (USA)
Roland Wohlgemuth Sigma-Aldrich, Member of Merck Group (Switzerland)
Vidya Velagapudi University of Helsinki (Finland)
David I. Broadhurst Edith Cowan University (Australia)
Cristina Andrés-Lacueva University of Barcelona (Spain)
Susan J. Sumner University of North Carolina (USA)
Ines Thiele National University of Ireland, Galway (Ireland)
Oliver Fiehn University of California, Davis (USA)
Mioara Larion National Cancer Institute (USA)